Clinical Trial Update: Dendritic Cell Vaccination for Patients With Acute Myeloid Leukemia in Remission [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating dendritic cell vaccination in patients with acute myeloid leukemia in remission has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Dendritic Cell Vaccination (dendritic cell vaccine)

Snippet

Sponsor: University Hospital, Antwerp | Conditions: Acute Myeloid Leukemia (AML) | Phase 1 | Status: COMPLETED